Trends in the Association between Pyoderma Gangrenosum and Autoimmune Hepatitis: Case Report and Review of the Literature

Background: Pyoderma gangrenosum (PG) is a neutrophilic dermatosis commonly associated with underlying systemic illness, typically of autoimmune origin. The association of PG with autoimmune hepatitis (AIH) has been reported but remains poorly recognized. Observations: We describe a case of PG manifesting 5 years following the diagnosis of AIH and conduct a literature review to determine the significance of this association. We identified a predisposition for young females and a tendency for PG to arise 4 to 12 years after the diagnosis of AIH during a period of disease quiescence. Additionally, fulminant hepatitis as the initial presentation of AIH appears to be a risk factor in the subsequent development of PG. Conclusions: These observations may provide important clues for the pathogenesis of PG in the context of AIH. Recognition of this association has important implications for dermatologists in the evaluation, workup, and management of patients with a history of AIH and suspected PG.

[1]  K. Shinkai,et al.  Etiology and Management of Pyoderma Gangrenosum , 2012, American Journal of Clinical Dermatology.

[2]  A. Qureshi,et al.  Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients , 2011, The British journal of dermatology.

[3]  F. Alvarez,et al.  Unusual Association Between Autoimmune Hepatitis and Severe Pyoderma Gangrenosum , 2010, Journal of pediatric gastroenterology and nutrition.

[4]  K. Boberg,et al.  Simplified criteria for the diagnosis of autoimmune hepatitis , 2008, Hepatology.

[5]  G. Goldenberg,et al.  Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis , 2005, The Journal of dermatological treatment.

[6]  C. Berking,et al.  Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts , 2000, Laboratory Investigation.

[7]  J. Koskinas,et al.  Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. , 1999, European journal of gastroenterology & hepatology.

[8]  P. Johnson,et al.  Meeting report: International autoimmune hepatitis group , 1993, Hepatology.

[9]  A. Banerjee Chronic active hepatitis, pyoderma gangrenosum and febrile panniculitis. , 1990, The British journal of clinical practice.

[10]  W. Su,et al.  Pyoderma gangrenosum: a review of 86 patients. , 1985, The Quarterly journal of medicine.

[11]  J. Sampson,et al.  PYODERMA GANGRENOSUM AND CHRONIC ACTIVE HEPATITIS: A CASE REPORT , 1982, The Australasian journal of dermatology.

[12]  I. Sarkany,et al.  Active chronic hepatitis and pyoderma gangrenosum: report of a case , 1979, Clinical and experimental dermatology.

[13]  R. Smallwood,et al.  The association of chronic active hepatitis with pyoderma gangrenosum. , 1978, Australian and New Zealand journal of medicine.

[14]  W. Weston,et al.  Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisone. , 1978, Archives of dermatology.

[15]  J. Byrne,et al.  Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases. , 1976, Archives of dermatology.